Overview
What is International Society For Pharmacoeconomics Outcomes Research?
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a global nonprofit organization with approximately 9,296 members. Based in Lawrenceville, New Jersey, their mission is to promote excellence in health economics and outcomes research, contributing to better decision-making for healthcare worldwide. ISPOR focuses on research related to clinical, economic, and patient-reported outcomes for health technologies, such as drugs, devices, diagnostics, and services. ISPOR facilitates the exchange of scientific knowledge through multiple meetings each year, including the North American and European conferences. They publish scientific journals, news magazines, and electronic newsletters, and develop consensus documents on outcomes research methods and their application in healthcare decisions. Additionally, ISPOR fosters education and the development of outcomes research at the local level through their regional chapters and student chapters. In 2022, ISPOR had over 9,296 members from 111 countries, 144 student chapters, and over 83 regional chapters. They published 3,122 pages of outcomes research and health policy papers in their three journals. ISPOR provides tools and resources for outcomes researchers, including good practices documents and a web-based database of research presentations given at their meetings. Through task forces, councils, and special interest groups, ISPOR continues to advance the science of pharmacoeconomics, health economics, and health outcomes research.
Official website here: www.ispor.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 96% (Four-Star out of Four Stars)
The International Society for Pharmacoeconomics Outcomes Research has achieved a commendable Four-Star rating from Charity Navigator, reflecting a high level of accountability and financial management. This rating is based entirely on their performance in the Accountability & Finance beacon, showcasing a strong commitment to transparency and responsible stewardship of resources.
Strengths of the organization are highlighted by their governance structure, which boasts 91% independent board members and a strong audit oversight committee. The charity demonstrates responsible financial practices with a low liabilities-to-assets ratio of 16.92% and an excellent program expense ratio of 80.05%, indicating that a significant portion of their budget is directed toward their mission-related activities.
While the overall rating is impressive, the data does not indicate any significant limitations or areas for improvement. The organization's policies on conflict of interest, whistleblower protection, and document retention are all in place, ensuring ethical operations and accountability. Overall, the International Society for Pharmacoeconomics Outcomes Research stands out as a well-managed nonprofit committed to its mission.
This AI summary has been generated from information found on Charity Navigator.
Is International Society For Pharmacoeconomics Outcomes Research legitimate?
International Society For Pharmacoeconomics Outcomes Research is a legitimate nonprofit organization registered as a 501(c)(3) entity. International Society For Pharmacoeconomics Outcomes Research submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $1,063,886
Professional Fundraising Fees: $0
Other Salaries and Wages: $4,786,201
For more financial information, click here
Official website here: www.ispor.org
What is the mission statement of International Society For Pharmacoeconomics Outcomes Research?
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a global non-profit organization committed to promoting excellence in health economics and outcomes research to enhance decision-making for healthcare globally. Its mission is to foster the exchange of scientific knowledge in pharmacoeconomics, health economics, and outcomes research, health policy, and the application of this research in healthcare decisions. With approximately 9,296 members, ISPOR provides a platform for researchers, clinicians, and policymakers to share and advance their work through multiple meetings, training courses, and publications. ISPOR's activities include publishing scientific journals, developing consensus documents, and fostering education and the development of outcomes research at the local level through regional and student chapters. In 2022, ISPOR held two conferences and published over 3,122 pages of research papers in its journals. The organization has over 9,296 members from 111 countries and had over 83 regional chapters and 144 student chapters worldwide. ISPOR also develops tools for outcomes researchers, such as good practices for outcomes research and a web-based database of research presentations given at ISPOR meetings.
Official website here: www.ispor.org
Who is the CEO of International Society For Pharmacoeconomics Outcomes Research?
Robert Abbott is the Ceo & Executive Director of International Society For Pharmacoeconomics Outcomes Research. The CEO's salary of International Society For Pharmacoeconomics Outcomes Research is $598,736 and their total compensation is $625,940.
Official website here: www.ispor.org
What is the revenue of International Society For Pharmacoeconomics Outcomes Research?
International Society For Pharmacoeconomics Outcomes Research's revenue in 2022 was $14,593,000.
Official website here: www.ispor.org
Who are the executives of International Society For Pharmacoeconomics Outcomes Research and what are their salaries?
The average compensation at International Society For Pharmacoeconomics Outcomes Research during 2022 was $110,379. There are 53 employees and 900 volunteers at International Society For Pharmacoeconomics Outcomes Research.
Here are 20 key members and their salaries (International Society For Pharmacoeconomics Outcomes Research's CEO's salary is $598,736 and their total compensation is $625,940):
- Compensation: $598,736
- Related: $0
- Other: $27,204
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $119,600
- Related: $0
- Other: $11,503
- Compensation: $280,985
- Related: $0
- Other: $25,858
- Compensation: $207,595
- Related: $0
- Other: $20,970
- Compensation: $195,059
- Related: $0
- Other: $20,853
- Compensation: $192,519
- Related: $0
- Other: $7,050
- Compensation: $184,154
- Related: $0
- Other: $11,049
- Compensation: $197,942
- Related: $0
- Other: $20,780
Official website here: www.ispor.org
Where can I find the form 990 for International Society For Pharmacoeconomics Outcomes Research?
International Society For Pharmacoeconomics Outcomes Research's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.ispor.org
Learn more at the official website: www.ispor.org
Mission Statement of International Society For Pharmacoeconomics Outcomes Research
The International Society For Pharmacoeconomics Outcomes Research (ISPOR) is a global non-profit organization committed to advancing the field of health economics and outcomes research. With a mission to promote research excellence and improve decision-making for health globally, ISPOR brings together approximately 9,296 members involved in the study of healthcare outcomes, including clinical, economic, and patient-reported outcomes of health technologies and services.
ISPOR facilitates the exchange of scientific knowledge through various channels. They host multiple meetings each year, providing a platform for researchers, policy makers, and professionals to discuss the latest developments in pharmacoeconomics and health economics. ISPOR publishes two scientific journals, a news magazine, and four electronic newsletters, further disseminating research findings and advancements in the field.
ISPOR's activities extend beyond publishing and education. They develop consensus documents on outcomes research methods and their application in healthcare decision-making. The organization also fosters the growth and development of outcomes research at the local level through regional chapters and student chapters worldwide. In 2022, ISPOR held two in-person/virtual conferences featuring over 4,000 scientific presentations and published 3,122 pages of research papers in its three journals.
Throughout the year, ISPOR's task forces, councils, and special interest groups work on developing tools and resources for outcomes researchers. These include 'good practices' guidelines, which have over 1,000,000 downloads annually, and a web-based database of over 64,000 research presentations given at ISPOR meetings. With a membership base in 111 countries, ISPOR continues its efforts to promote the science of pharmacoeconomics, health economics, and health outcomes research worldwide.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) significantly influences global health decision-making through its commitment to promoting excellence in health economics and outcomes research. With approximately 9,296 members from 111 countries, ISPOR facilitates an expansive forum for the exchange of scientific knowledge in fields such as pharmacoeconomics, health policy, and healthcare outcomes.
ISPOR plays a critical role in enhancing the application of health outcomes research in healthcare decisions by publishing essential findings in its journals, including *Value in Health*, and by producing a wealth of resources such as consensus documents that provide guidelines and good practices. Their conferences, which feature thousands of scientific presentations annually, foster collaboration among researchers, policymakers, and practitioners focused on improving health outcomes.
Through educational initiatives and the development of resources tailored for outcomes researchers, ISPOR equips constituents with tools to apply evidence-based practices effectively. Notably, the organization has a robust outreach through regional and student chapters worldwide, promoting the science of health economics and ensuring that knowledge is disseminated globally.
Additionally, ISPOR's extensive database of research presentations, which has over 64,000 entries, and its widely downloadable good practices tools, have become essential resources for researchers and practitioners alike, further establishing ISPOR as a cornerstone in the field of health economics and outcomes research.
This information is meant to be a general summary of International Society For Pharmacoeconomics Outcomes Research. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $157,836
- Program Service Revenue: $14,205,222
- Gross Receipts: $20,488,139
Assets and Liabilities:
- Total Assets: $23,939,884
- Total Liabilities: $4,053,006
- Net Assets: $19,886,878
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
MEETING REVENUE
Revenue
$11,010,606
EBULLETIN/TECH JOURNAL REVENUE
Revenue
$1,387,007
MEMBER SERVICES
Revenue
$1,070,780
EDUCATION AND SCIENTIFIC REVENUE
Revenue
$736,829
Organization Details
Founding Year
1995
Phone
(609) 586-4981Principal Officer
Robert Abbott
Main Address
505 LAWRENCE SQUARE BLVD SOUTH, LAWRENCEVILLE, NJ, 08648
Website
www.ispor.orgNTEE Category
Code: H02 - Medical research
If you are a representative of International Society For Pharmacoeconomics Outcomes Research and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.